Notably, miR-9-5p may contribute to GDM by targeting HK-2 (Hexokinase-2), which in turn regulates genes involved in glycolytic pathways such as GLUT1 (glucose transporter 1), PFK (phosphofructokinase), and LDH (lactate dehydrogenase) [43]. The gene discussed is HK2; the disease is gestational diabetes.